- Six out of 6.8 million people who got the J&J vaccine developed blood clots days after the shot.
- Signs of a blood clot include abdominal pain, severe headache, leg pain, and shortness of breath.
- Visit Business Insider's homepage for more stories.
Johnson & Johnson reported that six women, out of 6.8 million people dosed, developed cases of serious blood clots six to 13 days after vaccination. The blood clots occurred in women between 18 to 48 years old.
All women had a cerebral venous sinus thrombosis (CVST) blood clot, which is when there's a blood blockage in the brain channels. The blockage prevents the brain from draining blood and can lead to a hemorrhage. The women also had low levels of blood platelets.
In a briefing on Tuesday morning, the US Food and Drug Administration (FDA) said there is no evidence of a causal relationship between the vaccine and the blood clots.
Though the adverse event is extremely rare, the Centers for Diseases Control and Prevention (CDC) and FDA recommended a pause in vaccinating people with the J&J vaccine.
CVST blood clots have also been reported in a small number of people - mainly women under 60 - who got the AstraZeneca Covid-19 vaccine, which uses a similar vaccine technology to J&J.
How to spot symptoms of a blood clot
The CDC and FDA said patients should seek medical care if they have the following symptoms within three weeks of their J&J shot:
- Severe headache
- Abdominal pain
- Leg pain
- Shortness of breath
Other signs of a blood clot include:
- Chest pain
- Neurological symptoms, including severe and persistent headaches or blurred vision
In general, the World Health Organization recommends that if you have severe side effects four to 20 days after vaccination, you should go to the doctor.
Blood clots are typically treated with anti-clotting medicine. Nonetheless, the women who got blood clots after the J&J shot will receive other treatment, as anti-clotting drugs may be dangerous in their situation.
Severe complications from blood clots can be avoided if they're caught early.
The FDA and CDC are reviewing patient safety data before resuming J&J vaccinations.